Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130388 · ClinicalTrials.gov registry record · NA
The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis
A NA study, sponsored by Ohio State University.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02130388 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 10 participants.
The verdict
NCT02130388, a NA study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Sepsis is the body's response to a life-threatening infection. This study will determine if zinc supplementation is safe to use in patients with severe sepsis or septic shock. This study will also gather preliminary information to evaluate the impact that zinc has on the immune system (the body's defense system against infection) and whether zinc can help monocytes and macrophages (specific types of cells that remove infections from the body) work more effectively.
Interventions
- DIETARY_SUPPLEMENT Zinc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02130388
The ClinicalTrials.gov registry entry for NCT02130388 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zinc is the first listed.
NCT02130388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02130388 about?
NCT02130388 is a clinical study titled "The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis". Sepsis is the body's response to a life-threatening infection. This study will determine if zinc supplementation is safe to use in patients with severe sepsis or septic shock. This study will also gather preliminary information to evaluate the impact that zinc has on the immune system (the body's de...
What is the current status of trial NCT02130388?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2014-05. Estimated completion is 2019-03.
What interventions are being tested in trial NCT02130388?
The interventions under investigation include: Zinc (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02130388?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.